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Background: Quality of life (QoL) and posttraumatic stress symptoms (PTSS) were studied
in patients with soft tissue sarcoma (STS) of the extremities treated with isolated limb per-
fusion and delayed resection, with or without adjuvant irradiation.
Methods: Forty-one patients received a questionnaire that included the RAND-36 and
Impact of Event Scale.
Results: Thirty-nine STS survivors (16 [41%] male and 23 [59%] female; median age, 59 years;
range, 15–78 years) participated in the questionnaire survey (response rate, 95%). The median
age at perfusionwas 49 years (range, 14–72 years). No signiﬁcant differences were found inmean
scores between STS survivors and the reference group with the exception of a worse physical
functioning. Patients with amputations showed signiﬁcantly worse physical and social func-
tioning and more role limitations than patients whose limbs were saved. Eleven patients (28%)
had a PTSS score of 0, and eight patients (20.5%) had a score ‡ 26, which suggested the need for
psychological counseling. None of these eight patients had lost a limb. Patients who indicated
that the choice of treatment was made by the surgeon rather than collaboratively showed sig-
niﬁcantly decreased social functioning, more role limitations, and intrusion. Greater treatment
satisfaction was signiﬁcantly related to better social functioning, more vitality, better general
health perception, less intrusion, avoidance, and total Impact of Event Scale scores.
Conclusions: Even though STS survivors QoL was different from that of a reference group
only in physical functioning, one ﬁfth of the patients had PTSS. An amputation, the physicians
decision rather than the patients decision for the perfusion treatment and a low satisfaction with
the performed treatment negatively inﬂuenced QoL.
Key Words: Sarcoma—Isolated limb perfusion—Quality of life—Stress response symptoms.
For decades, soft tissue sarcomas (STS) were
known for their poor long-term outcome with respect
to local tumor control and survival, as well as func-
tional outcome. Developments in diagnostic imaging
and surgical treatment with adjuvant radiotherapy
were the cornerstones of the evolution over the past 30
years. Nowadays, STS patients have 5-year survival
rates of 60% to 70%.1,2 For patients with primarily
irresectable locally advanced STS, the so-called
hyperthermic isolated limb perfusion (ILP) with tu-
mor necrosis factor (TNF)-a and melphalan became
available in the early 1990s, with a limb salvage rate of
82%.3 The survival of patients with extremity STS is
not inﬂuenced by limb salvage procedures.4
The limb salvage treatment of STS with ILP is a
combined-modality treatment of regional chemother-
apy followed by delayed extensive surgical resections
with or without surgical reconstructions and/or adju-
vant high dose radiotherapy, sometimes followed
by systemic chemotherapy with curative or palliative
intent. ILP treatment is time consuming and has an
uncertain outcome. The risk of losing a limb after a
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limb salvage procedure is determined by the risk of
perioperative complications, local recurrences, and
short- and long-term treatment-induced morbidity.
Patients who are alive after treatment for a
potentially fatal disease are often analyzed in terms of
overall and disease-free survival. However, less
attention is paid to their quality of life (QoL) in these
years gained. Health is deﬁned by the World Health
Organization as a state of complete physical, mental
and social well-being and not merely the absence of
disease or inﬁrmity. Medical oncologists were one of
the ﬁrst groups of physicians to implement QoL
measurements into practice as the question was raised
to what extent quantity of life was gained at the ex-
pense of QoL.5 The need to investigate the QoL and
the psychological consequences of this combined
treatment became increasingly clear as more patients
with extremity STS became long-term survivors. It is
often hypothesized that for many people with cancer,
the survivor advantages of the intensive treatment far
outweigh the potential long-term side effects.6 Find-
ings in the literature are inconsistent concerning that
matter: worse, equal or even better QoL in cancer
survivors than in a healthy comparison group have
been reported.7,8 However, speciﬁc subgroups at risk
for a worse QoL have been identiﬁed, such as survi-
vors who are single, less educated, less involved in
decision making, or less satisﬁed with the received
medical treatment.9,10 Little is known about the QoL
of patients with locally advanced, primary irresec-
table STS of a limb who undergo TNF-based ILP as
an intentional limb-saving treatment.
This study was conducted to gain insight into the
QoL in this intensively treated group of patients and
into aspects possibly aﬀecting these patients QoL.
The study investigated whether STS survivors diﬀer
in QoL from a reference group and evaluated whe-
ther QoL and stress response symptoms in STS sur-
vivors are related to (1) sociodemographic aspects
(sex, age, education level, employment, and marital
status) and to (2) disease-related (time period since
perfusion, limb survival, local recurrence, presence of
metastases, and comorbidity) and treatment-related
(i.e., involvement in the choice of treatment and sat-
isfaction with treatment) aspects.
METHODS
Procedure and Patients
All patients with locally advanced STS who
underwent ILP with TNF-a and melphalan and an
intentional limb salvage treatment during the time
period 1991 to 2003 were eligible for the study. None
of the patients had metastases at the time of the ILP
treatment. Patients who were alive received a letter
explaining the aim of the study, an invitation to
participate in the questionnaire survey, and a prepaid
return envelope.
All patients underwent a complex diagnostic and
therapeutic pathway. Before treatment started, the
option of amputation or an intentional limb-saving
treatment with ILP was discussed. This study focuses
on the STS patients who received the intentional
limb-saving tumor treatment. The aﬀected limb re-
ceived an ILP with TNF-a and melphalan followed
by delayed resection This technique was described
previously.11 Most patients received adjuvant radio-
therapy (60–70 Gy).11 During the entire range of the
intentional limb-saving procedure, it was possible
that patients would still lose a limb as a result of
irresectability, vascular complications, wound-heal-
ing disturbances, or radiation-induced complica-
tions.3 The TNF-a–based ILP-containing treatment
and the series of patients were recently extensively
described.3,11 All patients were treated by following
institutional guidelines.
Measurements
Sociodemographic (sex, age, education level, and
employment and marital status) and disease-related
(time period since perfusion, limb survival, local
recurrence, presence of metastases at the time of
questionnaire completion, and comorbidity) data were
assessed from all patients. On a ﬁve-options scale,
patients could ﬁll in their perception of actual
involvement in the decision for treatment. Answers
ranged from ‘‘the doctor only’’ (1) to ‘‘the doctor and
myself in equal extent’’ (3) to ‘‘me only’’ (5).12 In
addition, patients were asked to score their satisfaction
with treatment received on a ﬁve-point scale from
‘‘very good’’ to ‘‘very bad.’’ Patients were invited to
indicate reasons for satisfaction and dissatisfaction.
Health-related QoL was investigated with a Dutch-
language version of the RAND-36,13 a multidimen-
sional self-report questionnaire that is identical to the
Short Form 3614 but uses a different scoring method.
The RAND-36 consists of the following domains:
physical functioning (10 items), social functioning (2
items), role impairment due to physical problems (4
items), role impairment due to emotional problems (3
items), mental health (5 items), vitality (4 items), pain
(2 items), general health perception (5 items), and
health change (1 item). After recoding and transfor-
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mation, scores on the subscales could range from 0 to
100. Higher scores indicate a better QoL. The internal
consistency of the subscales for the respondents in
this study was good (a ranged from .70 to .92).
Normative data are available for the healthy Dutch
population. The normative data compromise the
mean scores of a group of 1063 men (35%) and wo-
men (65%) from a random sample of the population
register of a municipality in the Netherlands (108,000
inhabitants). The mean age of the persons in the total
random sample was 44 years (range, 18–89 years).13
Posttraumatic stress symptoms (PTSS) were mea-
sured with the Dutch version of the Impact of Event
Scale (IES).15,16 This scale is often used in studies on
cancer patients.17 In this study, information was ob-
tained about the degree to which treatment for a
sarcoma was inﬂuencing the current daily life of the
respondent. Fifteen items measured intrusion (intru-
sively experiencing ideas, images, feelings, or bad
dreams about the event; seven items) and avoidance
of unpleasant feelings or memories of the event (eight
items) by using the answer categories not at all (0),
rarely (1), sometimes (3), and often (5) (intrusion:
range, 0–35; avoidance: range, 0–40). Items of the
two subscales are summed to compute a total score
(range, 0–75). A total score of > 26 is a strong
indication of clinically signiﬁcant PTSS for which
psychological help is recommended. The internal
consistency of this questionnaire was good (a was .84
for intrusion, .76 for avoidance, and .85 for the total
IES score).
Statistics
Statistical analyses were performed by using SPSS
for Windows (version 12.0; SPSS Inc., Chicago, IL).
Unpaired t-tests were computed to compare STS sur-
vivors with the reference group in the domains of QoL.
Pearson correlations, unpaired t-tests, and nonpara-
metric Mann-Whitney and Kruskal-Wallis tests were
conducted to examine the effects of sociodemograph-
ics and treatment- and disease-related variables on the
outcome measures. Correlation coefﬁcients <.30
indicate a weak association, those between .30 and .50
indicate a moderately strong association, and those
>.50 indicate a strong association.18
RESULTS
Forty-one (57%) of the 73 patients who had been
treated with an intentional limb salvage procedure for
locally advanced, irresectable STS at the Department
of Surgical Oncology at the University Medical
Center Groningen since 1991 were still alive. Thirty-
nine patients (16 [41%] male and 23 [59%] female;
median age, 59 years; range, 15–78 years) partici-
pated in the questionnaire survey (response rate,
95%). The median age at perfusion was 49 years
(range, 14–72 years). The median time since perfusion
was 7 years (range, 1–13 years). A ﬁfth of the patients
had completed primary school only, and only one
patient had a university degree. The median educa-
tion level was lower secondary school. A little more
than one third of the patients had a job, and one third
was retired. More than two thirds (69%) of the STS
survivors was married or cohabiting (Table 1).
Successful limb salvage was achieved in 30 patients,
and 9 patients underwent an amputation of the af-
fected limb. Amputation of the aﬀected limb was due
to massive necrosis after ILP, local recurrence, or
critical leg ischemia.3 The decision to amputate was
not inﬂuenced by the presence of metastases. At the
time of this study, four (44%) of the nine patients
whose limbs were amputated had metastases. Of the
30 patients whose limbs were saved, 6 patients (20%)
had metastases at the time of questionnaire comple-
tion. Thirty-three patients had a sarcoma in the lower
limb (31% thigh, 21% knee, and 33% lower leg), and
six (15%) had metastases in the upper limb. Three
patients had local recurrence, and 10 patients had
distant metastases at the time of ﬁlling in the ques-
tionnaire (Table 1). The vast majority did not expe-
rience comorbidity.
Nine patients responded that the choice was made
by the physician alone, and two patients indicated
that the choice was made by themselves. Almost half
of the patients judged that the physician mainly made
the choice of treatment, with their participation.
Thirty patients were very or rather satisﬁed with the
treatment, three patients were not, and six scored the
answer as neutral. Involvement in treatment choice
and satisfaction with treatment were not signiﬁcantly
related (Table 2).
Independent t-tests showed no signiﬁcant differ-
ences inmean scores between the STS survivors and the
reference group in most aspects of QoL, except in
physical functioning (P < .001) and role limitations
due to physical problems (P= .01). A tendency for a
worse social functioningwas found (P=.09; Table 3).
Eleven patients (28%) had a total stress response
symptom score of 0. Eight patients (20.5%) had a score
‡ 26, which suggested that psychological counseling
was needed.
No signiﬁcant diﬀerences were found between male
and female patients in QoL and PTSS. Younger STS
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survivors scored better on physical functioning than
older ones (r = ).34; P = .035). Educational level
was not signiﬁcantly related to QoL or PTSS in STS
patients. There was a signiﬁcant difference in only
one domain of QoL when patients employed for
wages were compared with the rest: they experienced
signiﬁcantly less pain (Mann-Whitney U-test, )2.47;
P = .014). Having or not having a partner did not
affect functioning in STS survivors. A Mann-Whit-
ney test showed that those whose limb was ampu-
tated reported signiﬁcantly worse physical (U =
)2.41; P = .016) and social (U = )2.27; P = .023)
functioning, and they reported more role limitations
due to physical (U= )2.39; P= .017) and emotional
(U = )2.45; P = .014) problems than those whose
limbs could be saved. No signiﬁcant differences were
found in mental health, vitality, pain, general health
perception, avoidance, intrusion, and total IES be-
tween the two groups. No signiﬁcant relationships
were found between time since initial treatment and
the various QoL domains and PTSS.
If patients had metastases at the time of the survey,
they reported signiﬁcantly worse physical functioning
(U= )2.13; P= .034) and more role limitations due
to physical (U = )2.14; P = .032) and emotional (U
= )2.92; P = .004) problems. There were no dif-
ferences in the other areas of QoL or in intrusion,
avoidance, and total stress response symptoms. None
of the nine patients with amputations had a score ‡
26 on the total IES. Of the 10 patients with metas-
tases, 2 had a score ‡ 26. The effects of the incidence
of local recurrence and chronic diseases on QoL and
STS could not be examined because only a few pa-
tients had experienced local recurrence (n = 3) or
experienced comorbidity (n = 4).
Kruskal-Wallis tests showed that those who were
less involved in the decision for treatment had sig-
niﬁcantly higher scores on intrusion (v2 = 11.37; P
= .023). Also, they tended to report more total IES
(v2 = 9.12; P = .058) and a worse social functioning
(v2 = 9.17; P= .057). Greater treatment satisfaction
was related to a better social functioning (r= ).36; P
= .024), more vitality (r = ).32; P = .046), and a
better general health perception (r= ).36; P= .028).
Higher treatment satisfaction was signiﬁcantly asso-
ciated with less intrusion (r = .57; P < .0001),
avoidance (r= .35; P= .27), and total IES (r= .58;
P < .0001). These correlation coefﬁcients ranged
from moderately strong to strong.
Fourteen patients (36%) indicated additionally why
they were satisﬁed with the treatment, 18 (46%)
indicated why treatment had discouraged them, and 7
(18%) mentioned both positive and negative aspects
of treatment. Positive experiences mentioned by 16 of
21 of the patients were that they were satisﬁed with







Primary school 8 21
Lower vocational degree 3 8
Lower secondary school 9 23
Middle secondary school 6 15
High secondary school 4 10
High vocational degree 8 21
University 1 2
Employment
Paid job 13 33









Upper limb 6 15














STS, soft tissue sarcoma.
a Median age, 59 years (range, 15–78 years).
TABLE 2. Treatment choice and satisfaction and
relationship between the two variablesa
Variable n %
Choice of treatment made by
Physician only 9 23
Mainly physician 19 49
Physician and patient equally 6 15
Mainly patient 3 8
Patient only 2 5
Satisfaction with treatment
Very satisﬁed 20 51
Rather satisﬁed 10 26
Neutral 6 16
Rather unsatisﬁed 1 2
Very unsatisﬁed 2 5
a The correlation coefﬁcient (r) between the choice of treatment
and satisfaction with treatment was ).19 (not signiﬁcant).
QUALITY OF LIFE AFTER ILP FOR SARCOMA 867
Ann. Surg. Oncol. Vol. 13, No. 6, 2006
the ﬁnal result and the fact that the course of treat-
ment was as explained and therefore expected. The
remaining ﬁve mentioned that they experienced the
treatment positively because they had expected worse
and because they had experienced little pain. Dis-
couraging arguments mentioned were the intensity of
treatment (20 of 25), a long recovery period (9 of 25),
or the fact that they had been seriously ill as a con-
sequence of the treatment (6 of 25).
DISCUSSION
The aim of this study was to gain insight into the
QoL and PTSS of patients with locally advanced,
primary irresectable STS of a limb who underwent an
intensive and extensive sarcoma treatment that con-
sisted of a TNF-a–based ILP followed by delayed
surgical resection with or without adjuvant high-dose
external beam radiotherapy as an intentional limb-
saving treatment.
Physical functioning and role limitations due to
physical problems were the only domains in which
our group of patients scored signiﬁcantly lower than
the reference group. The problems perceived in the
physical domains could be explained by the resection
of a large muscular compartment and often adherent
structures in the aﬀected part of the limb that the
sarcoma patients had undergone. Obviously, such
invasive surgery aﬀects the physical functioning of
these sarcoma patients. However, functioning in the
remaining QoL domains in these patients was the
same as in the reference group. It has been suggested
that patients with cancer seem to change their inter-
nal standards and their expectations about life during
treatment. Other studies also postulate that cancer
patients evaluate QoL according to their new expec-
tations and diﬀerent standards.5,19 The limitations
patients experience in physical functioning do not
seem to affect functioning in the other QoL domains.
The ﬁnding of a surprisingly high percentage
(20.5%) of patients having clinically increased PTSS
is in contrast to literature showing a prevalence of
clinically high PTSS among people with cancer,
varying from 3% to 12%, depending on the cancer
treatment.20–23 The 20.5% PTSS rate found is this
study is comparable to rates with more traditional
traumatic events in general samples, such as rape,
war, disaster, and accidents.21 To distinguish those in
our group of patients who had more problems con-
cerning QoL and PTSS, we investigated the effects of
sociodemographic and disease- and treatment-related
variables.
Sociodemographics
Younger STS survivors scored better on physical
functioning than older STS survivors. Some other
QoL studies also showed that the physical autonomy
score was aﬀected by age.24,25 In the other QoL do-
mains and PTSS, we found no associations with age.
This is in contrast with the literature reporting that
younger age is a risk factor for psychosocial distress,
anxiety, and depressive symptoms among cancer
survivors.19,26
Other sociodemographic variables, such as sex,
education level, and marital status, were not related
to QoL and PTSS in our studies. This is diﬀerent
from ﬁndings in literature that show that women tend
to develop somatic complaints more quickly after
negative life events,24,27 that a higher educational le-
vel is associated with a higher QoL in the general





mean (SD) t P
QoL
Physical functioning 55.6 (30.0) 81.9 (23.2) )5.42 <.001
Social functioning 79.8 (25.1) 86.9 (20.5) )1.75 .09
Role limitations: physical 61.6 (41.4) 79.4 (35.5) )2.62 .01
Role limitations: emotional 87.0 (26.8) 84.1 (32.3) 0.63 .53
Mental health 76.7 (16.4) 76.8 (18.4) )0.04 .97
Vitality 64.6 (18.9) 67.4 (19.9) )0.90 .37
Pain 82.2 (21.2) 79.5 (25.6) 0.78 .44
General health perception 69.1 (19.1) 72.7 (22.7) )1.13 .26





STS, soft tissue sarcoma; ILP, isolated limb perfusion; QoL, quality of life.
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population,19,24 and that having a partner is a pre-
dictor of better well-being in the general population,
particularly in men.19,26 There was a signiﬁcant dif-
ference in one domain of QoL when patients em-
ployed for wages were compared with the rest: they
experienced signiﬁcantly less pain. This could be a
chance ﬁnding. Another suggestion is that work
provides a distraction and reduces pain sensations.
More research is needed to evaluate this ﬁnding.
Illness-Related Variables
Patients with an amputated limb had a worse QoL
score in physical and social functioning and in role
limitations due to physical and emotional problems.
This is in contrast with the literature, which showed
no diﬀerences in QoL between patients whose limb
was amputated and patients who were treated with
conservative surgery and adjuvant radiation treat-
ment.28–30 These studies, however, describe patients
who were randomized between amputation and limb-
saving treatment. In our group, all treatments started
intentionally with a limb-saving purpose. Our results
suggest that once the patients are on the pathway
where limb-saving treatment seems possible, an
eventual amputation actually may make a difference
that results in a decreased perception of QoL in some
domains.
Even though more QoL problems were found in
patients whose limb was amputated, it seemed that
none of these patients had a posttraumatic response
symptom score that was indicative of need for pro-
fessional psychosocial care. A hypothesis for this
phenomenon is that the loss of a limb releases pa-
tients from the insecurity of a possible loss in the
future. The threat of local recurrence and further
damage to the limb due to long-term eﬀects of radi-
ation or vascular incompetence may be like a sword
above the head that may fall at any moment. An
equal percentage (20%) of patients with metastasized
disease and in the complete study group had a clini-
cally increased PTSS score. Patients with metastasis
did have problems in physical functioning and role
limitations due to physical and emotional problems.
We found no eﬀect of time in relation to QoL; this
suggests that physical functioning problems are more
permanent. In Lampert and associates study,31 pa-
tients with lower extremity STS were more at risk to
become disabled than patients with STS in other
areas of the body. In our own data, the number of
upper extremity STS patients (n = 3) was too small
to detect signiﬁcant differences in QoL and PTSS
compared with patients whose affected limb was a
lower extremity.
Choice of Treatment
This study shows that patients who indicated that
the surgeon made the treatment choice rather than
they themselves showed decreased social functioning,
more role limitations due to physical problems, and
higher levels of intrusion. This is in agreement with
other studies reporting that patients beneﬁt from
participating in medical decision making.10 Despite
all the reasonable doubts patients may have, it seems
important that the patient at least be involved in the
ﬁnal decision for his or her treatment. Other studies
also mention that patients who perceive that they
have decisional control in their treatment may regain
perception of control over the disease as well. This
may ultimately lead to a higher QoL.32–36 It may be
that greater attention should be paid to the commu-
nication of treatment options and their consequences
to the patient so that the patient is better able to
make an informed decision.
Our results also showed that patients who were
more satisﬁed with treatment reported less PTSS and
a better QoL—a ﬁnding in line with earlier re-
search.10,37–40 In contrast to other studies, no signif-
icant relationship was found in this study between
decision involvement and treatment satisfaction.10,39
In the light of data indicating that 20.5% of the STS
survivors experience PTSS symptoms even years after
treatment and that patients, in particular those whose
limb was amputated, have problems in the physical
QoL domains, identifying ways to prevent or relieve
these symptoms should be considered. A suggestion
would be a multimodal rehabilitation program
including a physical and a psychosocial program that
might help reduce the problems in the physical do-
mains and the psychosocial distress in these patients.
An intensive multifocus rehabilitation program for
cancer patients after completion of their cancer treat-
ment seemed to have immediate and longer-term
beneﬁcial eﬀects on physiological functioning and
QoL.41 Furthermore, attention should be paid to the
issue of collaborative decision making, which may be
better achieved with informing the patient more com-
prehensively about treatment options and possible
consequences. Attention to communication issuesmay
also increase patient satisfaction.
The inclusion of a validated generic QoL question-
naire and the high response rate (95%) are the strengths
of this study. However, only 41 patients (57%) of the
original study population of 73 patients were eligible
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because the remaining 32 patientswere dead at the time
of the survey. In addition, this study was a retrospec-
tive cross-sectional study. The measurement of QoL in
STS patients is a dynamic rather than a static process
that requires reassessment. Consecutive QoL mea-
surements may give insight into change over time and
causal relationships between variables.
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